kras mutation and glutathion Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation the Potential of Immunotherapy KRAS G12V mutation-selective requirement for
KRAS G12V mutation selective requirement for ACSS2 in colorectal adenoma formation: Cell Reports Impact of KRAS mutation on the tumor microenvironment in colorectal cancer KRAS mutation: from undruggable to druggable in cancer Signal Transduction and Targeted Therapy Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell
Pay in 4 interest-free payments of $6.83 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



